Endothelial Activation and Stress Index (EASIX) to Predict Survival in T or NK Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis
Introduction: Lymphoma is the most common underlying cause of secondary hemophagocytic lymphohistiocytosis (HLH). In Asian countries, T or NK-cell lymphoma-associated HLH (T/NK-LAHLH) is more common than B-cell lymphoma-associated HLH. There are no established prognostic markers for T/NK-LAHLH. Endothelial Activation and Stress Index (EASIX) is a marker of endothelial activation and could predict mortality in patients treated with allogeneic stem cell transplantation. Whether EASIX could predict survival in T/NK-LAHLH remains to be determined. Materials and Methods: Patients with T/NK-LAHLH were included. EASIX was calculated by the formula: lactate dehydrogenase (U/L)×creatinine (mg/dL)/thrombocytes (10⁹ cells per L). The diagnosis of HLH was based on the HLH-2004 criteria. Only patients with a histological diagnosis and follow-up were included. The subtyping was based on the 2016 World Health Organization classification of lymphoid neoplasms. X-tile was used to determine the best cutoff of EASIX for survival prediction. Results: A total of 212 cases of T/NK-LAHLH were identified. The most common subtype of T/NK cell malignancy was extranodal NK/T cell lymphoma, nasal type (57, 26.9%) followed by aggressive NK cell leukemia (55, 25.9%) and peripheral T cell lymphoma, not otherwise specified (29, 13.7%). The best cutoff of EASIX for predicting 60-day survival was 40.1. Patients with high EASIX values (>40.1) had a significantly poorer 60-day survival than those with low EASIX values (≤40.1) (60-day survival rate: 15.6% vs. 63.9%, p<0.0001). Patients with high EASIX also showed significantly poorer overall survival (median survival: 14 days vs. 79 days, p<0.0001). For patients with NK cell malignancies, a higher EASIX also significantly predicted a reduced 60-day survival rate (p<0.0001) and overall survival (p<0.0001). Patients with high EASIX values showed significantly lower levels of hemoglobin, neutrophil count, albumin, and fibrinogen and higher levels of aspartate aminotransferase, alanine aminotransferase, and triacylglycerol (p values all < 0.05). EASIX>40.1 (hazards ratio[HR] 3.60, 95%CI: 2.31-5.60; p<0.0001), fibrinogen≤1.5g/L (HR 1.67, 95%CI: 1.07-2.58; p=0.023), and age>60 (HR 1.76, 95%CI:1.14-2.71; p=0.011) were identified as independent predictors of worse 60-day survival in multivariate analysis. A prognostic index was established by combining these three independent predictors. We assigned a weighted score of 1 to fibrinogen and age, and 2 to EASIX. Finally, a prognostic index for T/NK-LAHLH (T/NK-LAHLH-PI) ranged from 0 to 5 was established (T/NK-LAHLH-PI: low-risk 1, intermediate-risk 2, high-risk ≥2). T/NK-LAHLH-PI significantly predicted different 60-day survival rates (low-risk 77.3% vs. intermediate-risk 50.1% vs. high-risk 24.9%, p<0.0001) and overall survival (median survival: low-risk 340 days vs. intermediate-risk 63 days vs. high-risk 20 days, p<0.0001). Conclusions: Our study demonstrated that EASIX was a robust marker for predicting outcomes in patients with T/NK-LAHLH. T/NK-LAHLH-PI, a prognostic index containing EASIX, could be used to predict the outcomes of patients with T/NK-LAHLH.
Authors
- Yi Miao (ORCID: https://orcid.org/0000-0003-1799-1448)
- Lijia Zhai
- Wenyu Shi (ORCID: https://orcid.org/0000-0002-2371-3332)
- Haiying Hua (ORCID: https://orcid.org/0000-0002-7656-9880)
- Min Zhao (ORCID: https://orcid.org/0000-0001-5498-3434)
- Yuqing Miao (ORCID: https://orcid.org/0000-0003-1529-3195)
- Bing-Zong Li (ORCID: https://orcid.org/0000-0002-2732-9354)
- Jingyan Xu (ORCID: https://orcid.org/0000-0002-4093-855X)
- Jianfeng Zhu (ORCID: https://orcid.org/0000-0002-4453-611X)
- Ping Liu (ORCID: https://orcid.org/0000-0003-1895-338X)
- Jianyong Li (ORCID: https://orcid.org/0000-0002-9931-4055)
- Xiaoyan Xie (ORCID: https://orcid.org/0000-0002-9761-9525)
- Maozhong Xu
- Min Xu (ORCID: https://orcid.org/0009-0003-5839-0259)
- Weiying Gu (ORCID: https://orcid.org/0000-0003-4913-1610)
- Yunping Zhang (ORCID: https://orcid.org/0000-0002-2444-3565)
- Haiwen Ni (ORCID: https://orcid.org/0009-0004-0753-7481)
- Tao Jia (ORCID: https://orcid.org/0009-0006-3733-9798)
- Guo‐Qiang Lin (ORCID: https://orcid.org/0000-0002-8209-5263)
- Xuzhang Lu
- Yun Zhuang
- Wanchuan Zhuang
- Jing Zhang (ORCID: https://orcid.org/0000-0002-7650-4702)
- Chunling Wang
Institutions
- Jiangnan University (CN)
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Nantong University (CN)
- Soochow University (CN)
- Affiliated Hospital of Nantong University (CN)
- Huaian First People’s Hospital (CN)
- Wuhu Fourth People Hospital (CN)
- Jiangyin People's Hospital (CN)
- Zhangjiagang First People's Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Wuxi Fourth People's Hospital (CN)
- Yancheng First People's Hospital (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Second People’s Hospital of Huai’an (CN)
- Wuxi No.2 People's Hospital (CN)
- The First People’s Hospital of Lianyungang (CN)
- Northern Jiangsu People's Hospital (CN)
- Yixing People's Hospital (CN)
- Xian Yang Central Hospital (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Wuxi People's Hospital (CN)
- Southeast University (CN)
- Yangzhou University (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Blood
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1182/blood-2024-205535
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00